Jiangxi Bio Sets Final IPO Price at HK$11.2 per Share, Hong Kong Public Offering Heavily Oversubscribed

Stock News
Jun 29

The final allocation results for the initial public offering of JIANGXI BIO (06915) have been announced.

The company issued a total of 36.2345 million shares globally, with the Hong Kong public offering portion accounting for 10% and the international offering making up the remaining 90%.

The final offer price has been set at HK$11.2 per share.

Net proceeds from the global offering are expected to be approximately HK$338.8 million.

Each board lot consists of 500 shares.

The company's H-shares are scheduled to commence trading on the Stock Exchange at 9:00 a.m. on Tuesday, June 30, 2026 (Hong Kong time).

The Hong Kong public offering was significantly oversubscribed by approximately 476.56 times.

The international offering portion was oversubscribed by about 4.25 times.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10